Showing results (1831-1840 of 2,885) with videos related to

Sort By:
Pageof 289
Molecular Diversity|July 16, 2024
Virtual screening, ADME prediction, drug-likeness, and molecular docking analysis of Fagonia indica chemical constituents against antidiabetic targetsRabia Riaz, Shagufta Parveen, Nusrat Shafiq, et al.
Molecular Diversity|July 16, 2024
Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammationMohammed M Ghoneim, Mohamed A Abdelgawad, Nadia A A Elkanzi, et al.
Molecular Diversity|July 1, 2024
In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathwayHuixian Zhou, Zhiwen Wu, Yannan Zhang, et al.
Molecular Diversity|July 2, 2024
Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinomaBhavya Banjan, Riya Vishwakarma, Krishnapriya Ramakrishnan, et al.
Molecular Diversity|September 3, 2024
Flavonol derivatives containing piperazine and quinoxaline fragments: synthesis and antifungal activityYi Liu, Hui Xin, Yuhong Wang, et al.
Molecular Diversity|August 29, 2024
Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitorsMonisha Sivanandhan, Sutha Ragupathy, Arumugam Thangamani, et al.
Molecular Diversity|May 26, 2024
Innovative cascade reaction for 2H-indazole derivative synthesisAnnu Choudhary, Rohit Patel, Dweipayan Goswami, et al.
Molecular Diversity|June 10, 2024
Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated reviewTanushree Manna, Sumit Maji, Mousumi Maity, et al.
Molecular Diversity|June 8, 2024
Design, spectroscopic characterizations, and biological investigation of oxospiro[chromine-4,3-indolene]-based compounds as promising antiproliferative EGFR inhibitors and antimicrobial agentsAbdullah Yahya Abdullah Alzahrani, Moustafa O Aboelez, Moumen S Kamel, et al.
Molecular Diversity|May 21, 2024
Investigating the potent TOPO IIα inhibitors in breast cancer through the study of computational drug discovery research approachesPriyanka Paul, Md Iftehimul, Dipta Dey, et al.
Pageof 289